H.R. 4752: Reducing Hereditary Cancer Act

This bill, known as the "Reducing Hereditary Cancer Act," aims to enhance access to genetic testing and preventive measures for individuals who have a hereditary cancer risk. It proposes amendments to the Social Security Act specifically addressing coverage for genetic testing, risk-reducing surgeries, and screenings associated with hereditary cancers.

Hereditary Cancer Genetic Testing

The bill stipulates the following regarding genetic testing:

• It requires that individuals with a family history of a hereditary cancer gene mutation or any personal or family history that raises suspicion for hereditary cancer should have access to germline mutation testing.
• The term "germline mutation testing" is defined as genetic testing for inherited mutations that aligns with established clinical practice guidelines from recognized oncology organizations.
• The legislation aims to lift certain frequency limitations on genetic testing for individuals deemed eligible based on their hereditary cancer risk.
• These amendments would take effect from the date of the legislation's enactment.

Coverage of Preventive Surgeries

The bill also covers specific preventive surgeries for individuals identified as having a high risk of developing cancer:

• It states that surgeries intended to reduce cancer risk, based on evidence-based guidelines, shall be deemed reasonable and necessary for treatment under Medicare.
• Similar to genetic testing provisions, any amendments related to coverage for these surgeries would be applicable from the date the law is enacted.

Coverage of Evidence-Based Screenings

Furthermore, the bill seeks to improve access to screenings for those with hereditary cancer gene mutations:

• The legislation mandates that the Secretary of Health and Human Services should modify coverage limitations for screenings in alignment with evidence-based guidelines, ensuring these individuals receive screenings annually or as recommended.
• Screening methods mentioned in the bill include mammography, breast MRI, colonoscopy, and PSA testing, with the potential for more screening modalities as recommended by clinical guidelines.
• These amendments regarding screenings would also take effect after the bill is enacted.

Conclusion on Impact

The overall goal of the "Reducing Hereditary Cancer Act" is to ensure better preventive health measures through genetic testing and screening for those at high risk of hereditary cancers, ultimately seeking to reduce cancer incidence through early identification and intervention.

Relevant Companies

None found.